Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK GEORGE CARMICHAEL

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1811973043
CMS profile
1013085
Location
RANCHO MIRAGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$5,394.54

236 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $5,394.54 236

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
Novartis Pharmaceuticals Corporation $377.99 19
Regeneron Healthcare Solutions, Inc. $286.28 13
Janssen Biotech, Inc. $283.52 17
Merck Sharp & Dohme LLC $249.93 11
Daiichi Sankyo Inc. $226.28 8
Seagen Inc. $224.62 10
AstraZeneca Pharmaceuticals LP $201.13 10
Galvanize Therapeutics, Inc $157.55 1
Blueprint Medicines Corporation $147.32 3
Amgen Inc. $146.04 8
Gilead Sciences, Inc. $140.02 5
Rigel Pharmaceuticals, Inc. $138.79 4
Genentech USA, Inc. $135.99 9
GlaxoSmithKline, LLC. $132.58 8
PFIZER INC. $130.11 7
Ipsen Biopharmaceuticals, Inc $123.03 5
Karyopharm Therapeutics Inc. $119.94 4
Celgene Corporation $110.56 5
E.R. Squibb & Sons, L.L.C. $110.07 6
Dendreon Pharmaceuticals LLC $107.21 4
AVEO Pharmaceuticals, Inc. $91.99 4
Immunocore Limited $88.14 1
Pharmacyclics LLC, An AbbVie Company $87.79 4
SOBI, INC $82.30 3
Mirati Therapeutics, Inc. $81.31 4
Bayer Healthcare Pharmaceuticals Inc. $80.98 3
Puma Biotechnology, Inc. $79.50 3
Astellas Pharma US Inc $74.00 4
Verity Pharmaceuticals Inc. $72.18 3
Foundation Medicine, Inc. $61.61 3
Boehringer Ingelheim Pharmaceuticals, Inc. $60.82 2
ARRAY BIOPHARMA INC $60.56 3
ImmunoGen, Inc. $56.29 2
Takeda Pharmaceuticals U.S.A., Inc. $55.64 2
GENZYME CORPORATION $50.42 3
Kite Pharma, Inc. $48.95 2
Alexion Pharmaceuticals, Inc. $48.80 2
Pharmacosmos Therapeutics Inc. $46.28 2
Incyte Corporation $46.06 2
Eisai Inc. $43.87 2
Stemline Therapeutics Inc. $42.55 2
Spectrum Pharmaceuticals Inc. $38.86 2
Jazz Pharmaceuticals Inc. $37.13 1
CSL Behring $36.15 2
Sumitomo Pharma America, Inc. $35.56 2
Lilly USA, LLC $30.55 2
Coherus Biosciences Inc. $28.75 1
CTI BioPharma Corp. $26.00 1
Adaptive Biotechnologies Corporation $24.55 1
Agios Pharmaceuticals, Inc. $24.50 1
SERVIER PHARMACEUTICALS LLC $24.13 1
MorphoSys, US Inc. $23.76 1
Deciphera Pharmaceuticals Inc. $23.09 1
Blue Earth Diagnostics Limited $22.93 1
RECORDATI_RARE_DISEASES_INC. $20.97 1
EMD Serono, Inc. $20.38 1
TerSera Therapeutics LLC $19.92 1
AbbVie Inc. $18.98 1
Sun Pharmaceutical Industries Inc. $16.98 1
Janssen Pharmaceuticals, Inc $12.35 1

Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARK GEORGE CARMICHAEL

NPI 1811973043 · CMS profile ID 1013085

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

RANCHO MIRAGE, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1811973043?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARK GEORGE CARMICHAEL, NPI 1811973043, CMS profile ID 1013085. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1811973043?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MARK GEORGE CARMICHAEL, NPI 1811973043, CMS profile ID 1013085. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1811973043?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MARK GEORGE CARMICHAEL, NPI 1811973043, CMS profile ID 1013085, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 236 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1811973043?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

236 matching records · $5,394.54 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 236 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 236.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Pharmacyclics LLC, An AbbVie Company $23.5110/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998283037 CMS
Amgen Inc. $13.7710/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020014193 CMS
Regeneron Healthcare Solutions, Inc. $20.7710/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999113269 CMS
Regeneron Healthcare Solutions, Inc. $0.8010/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999113273 CMS
Daiichi Sankyo Inc. $29.8110/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006515309 CMS
Kite Pharma, Inc. $29.4210/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025267769 CMS
Incyte Corporation $24.4610/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044780661 CMS
Puma Biotechnology, Inc. $21.5310/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059054397 CMS
Daiichi Sankyo Inc. $23.1910/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1006513693 CMS
Janssen Biotech, Inc. $16.7010/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988664591 CMS
AstraZeneca Pharmaceuticals LP $14.5810/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015960951 CMS
Janssen Biotech, Inc. $25.5510/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988664593 CMS
Janssen Biotech, Inc. $11.2910/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988664595 CMS
Celgene Corporation $29.0610/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015563737 CMS
Seagen Inc. $33.7410/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995665695 CMS
Blueprint Medicines Corporation $92.1610/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051258761 CMS
Amgen Inc. $32.3310/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1020014199 CMS
PFIZER INC. $18.3410/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1050425231 CMS
RECORDATI_RARE_DISEASES_INC. $20.9710/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1060351237 CMS
Foundation Medicine, Inc. $21.6610/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1058789675 CMS
Novartis Pharmaceuticals Corporation $16.2610/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641645 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.9709/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 996599617 CMS
GlaxoSmithKline, LLC. $14.9809/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003256623 CMS
Merck Sharp & Dohme LLC $13.2109/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048595847 CMS
Janssen Biotech, Inc. $26.8909/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988664597 CMS
Celgene Corporation $28.4109/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1015563721 CMS
GENZYME CORPORATION $14.1709/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049943737 CMS
Takeda Pharmaceuticals U.S.A., Inc. $27.3109/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055364341 CMS
Astellas Pharma US Inc $17.6809/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1034512322 CMS
AstraZeneca Pharmaceuticals LP $17.2809/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011496793 CMS
Blueprint Medicines Corporation $28.3309/18/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1051258725 CMS
Seagen Inc. $28.1009/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995665681 CMS
Novartis Pharmaceuticals Corporation $23.7309/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641625 CMS
Novartis Pharmaceuticals Corporation $20.3109/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641619 CMS
Spectrum Pharmaceuticals Inc. $19.8509/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1059885059 CMS
Novartis Pharmaceuticals Corporation $19.3509/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641595 CMS
ARRAY BIOPHARMA INC $20.8409/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049334521 CMS
GlaxoSmithKline, LLC. $17.2209/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1003256297 CMS
Novartis Pharmaceuticals Corporation $17.9509/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641631 CMS
Regeneron Healthcare Solutions, Inc. $36.0109/04/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999113265 CMS
Mirati Therapeutics, Inc. $21.6709/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057987603 CMS
Janssen Biotech, Inc. $24.3908/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988664599 CMS
Rigel Pharmaceuticals, Inc. $34.6308/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1033431577 CMS
Seagen Inc. $33.0608/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 995665642 CMS
Ipsen Biopharmaceuticals, Inc $29.6508/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1045429713 CMS
AVEO Pharmaceuticals, Inc. $21.7708/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049062325 CMS
Verity Pharmaceuticals Inc. $22.9308/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1019430805 CMS
Janssen Pharmaceuticals, Inc $12.3508/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988576826 CMS
Merck Sharp & Dohme LLC $28.4308/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1048595835 CMS
Novartis Pharmaceuticals Corporation $22.6108/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991641613 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $3,309.32 172
PY2020 $2,927.50 164
PY2021 $4,116.56 189
PY2022 $5,677.41 252
PY2023 $5,394.54 236
PY2024 $4,926.95 220
PY2025 $5,876.58 237

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2024 Principal investigator $1,600.00 1
PY2023 Principal investigator $705.00 2
PY2022 Principal investigator $113,205.11 6
PY2021 Principal investigator $237,473.33 14
PY2020 Principal investigator $263,096.68 15
PY2019 Principal investigator $30,865.04 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

1 record in PY2024

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 PFIZER INC. $1,600.00 12/17/2024 Non-covered Recipient Entity
Desert Hematology Oncology Medical Group Inc
A PHASE 3 RANDOMIZED DOUBLEBLIND PLACEBOCONTROLLED STUDY OF TALAZOPARIB WITH ENZALUTAMIDE IN METASTATIC CASTRATIONRESISTANT PROSTATE CANCER No dispute reported 06/30/2026 1130974152